<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Evaluation of oxidative stress parameters in dogs with brachycephalic obstructive airway syndrome before and after surgery</dc:title><dc:creator>Erjavec,	Vladimira	(Avtor)
	</dc:creator><dc:creator>Vovk,	Tomaž	(Avtor)
	</dc:creator><dc:creator>Nemec Svete,	Alenka	(Avtor)
	</dc:creator><dc:subject>brachycephalic  obstructive  airway  syndrome</dc:subject><dc:subject>malondialdehyde</dc:subject><dc:subject>superoxide  dismutase</dc:subject><dc:subject>glutathione peroxidase</dc:subject><dc:subject>oral surgery</dc:subject><dc:description>Abstract Introduction: Canine brachycephalic obstructive airway syndrome (BOAS) is a conformation-related respiratory disorder  of  dog  breeds  having  congenitally  flattened  facial  and  skull  anatomy.  The  aim  of  the  study  was  to  determine  oxidative  stress parameters, the lipid peroxidation product malondialdehyde, and antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase in BOAS patients before and after surgical treatment and in healthy brachycephalic dogs. Material and Methods: Nine healthy brachycephalic dogs that had not undergone surgery and 39 BOAS patients were included in the study. The BOAS patients were  classified  as  grade  1  (5/34),  grade  2  (16/34),  and  grade  3  (13/34) based on  the  decrease  in  the  radius  of  the  airway  in  the larynx. In BOAS patients, oxidative stress parameters were determined before and two weeks after surgery, while in control dogs, blood samples were collected only on inclusion to the study. Results: All BOAS patients showed various degrees of improvement in clinical signs after surgery. Significantly lower (P &lt; 0.05) SOD activity was found in grade 2 and 3 BOAS patients than in grade 1  patients.  Two  weeks  after  surgery,  a  significant  (P  &lt;  0.05)  increase  in  SOD  activity  in  grade  2  and  3  patients  was  observed. Conclusion: Antioxidant enzyme SOD may play an important role in BOAS and can be used as a biomarker of antioxidant status assessment in BOAS patients. </dc:description><dc:date>2021</dc:date><dc:date>2021-10-12 13:08:58</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>132095</dc:identifier><dc:identifier>UDK: 636.7.09:616</dc:identifier><dc:identifier>ISSN pri članku: 2450-7393</dc:identifier><dc:identifier>DOI: 10.2478/jvetres-2021-0027</dc:identifier><dc:identifier>COBISS_ID: 64497411</dc:identifier><dc:language>sl</dc:language></metadata>
